Psilocybin therapy shows effectiveness for veterans with severe PTSD in new trial

A preliminary U.S. clinical trial, published in *Communications Medicine*, indicates psilocybin-assisted therapy is safe and highly effective for veterans with treatment-resistant PTSD. The study reported 75% of participants achieved remission one month after treatment, with no serious adverse events, offering a potential new therapeutic avenue for a population with significant unmet needs.